Cargando…
Thirty-Day Mortality and Morbidity in COVID-19 Positive vs. COVID-19 Negative Individuals and vs. Individuals Tested for Influenza A/B: A Population-Based Study
Background: As of October 2020, COVID-19 has caused 1,000,000 deaths worldwide. However, large-scale studies of COVID-19 mortality and new-onset comorbidity compared to individuals tested negative for COVID-19 and individuals tested for influenza A/B are lacking. We investigated COVID-19 30-day mort...
Autores principales: | Nersesjan, Vardan, Amiri, Moshgan, Christensen, Hanne K., Benros, Michael E., Kondziella, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734212/ https://www.ncbi.nlm.nih.gov/pubmed/33330562 http://dx.doi.org/10.3389/fmed.2020.598272 |
Ejemplares similares
-
COVID-19 and the subsequent risk of mental disorders: A nationwide study of all SARS-CoV-2 PCR test results in Denmark
por: Nersesjan, Vardan, et al.
Publicado: (2023) -
Case Report: Resting-State Brain-Networks After Near-Complete Hemispherectomy in Adulthood
por: Fisher, Patrick M., et al.
Publicado: (2022) -
Global warming and neurological practice: systematic review
por: Amiri, Moshgan, et al.
Publicado: (2021) -
SARS-CoV-2 and autoantibodies in the cerebrospinal fluid of COVID-19 patients: prospective multicentre cohort study
por: Nersesjan, Vardan, et al.
Publicado: (2023) -
Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up
por: Nersesjan, Vardan, et al.
Publicado: (2021)